NYSE:TMOLife Sciences
Thermo Fisher Partnership With PRECISE Puts Proteomics At Core Of TMO Story
Thermo Fisher Scientific (NYSE:TMO) has entered a collaboration with Precision Health Research, Singapore (PRECISE) on a large-scale proteomics biobank initiative.
The PRECISE-SG100K project will use Thermo Fisher platforms, including Olink PEA and the Orbitrap Astral mass spectrometry system, in one of Asia’s largest longitudinal population health studies.
The partnership focuses on building regulatory-grade biobank infrastructure and integrating complementary proteomics technologies for...